FDA Grants Orphan Drug Designation To Sanofi’s (SNY) Riliprubart - Insider Monkey
  Parliamentarian reverses course, allows orphan drug provision in megabill - Politico
  Orphan Drug Designation: Opening Doors for Rare Cancer Treatments [Mesothelioma and More] - Mesothelioma Guide
  Opinion
  Article
  Orphan Cures Act re-added to Trump tax bill as Senate prepares to begin vote-a-rama - Fierce Pharma
  Congress needs to fix a policy that's blocking rare disease research
  Orphan drug designations for a precision medicine, P value = 0.99. - researchgate.net